Areas of Practice

Fleet Phospho-soda^®

Representing the Injured in Nevada

C.B. Fleet has recalled the Phospho-soda® laxative that it has aggressively promoted since the early 1990s as a safe bowel cleanser for colonoscopy and medical procedure preparation. Phospho-soda® is an over-the-counter saline laxative consisting mostly of monobasic sodium phosphate monohydrate and dibasic sodium phosphate heptahydrate. It is often taken to prepare for colonoscopy.

Fleet® Phospho-soda® works by drawing liquid from the body into the colon; therefore it can cause severe dehydration that can lead to kidney damage. Phospho-soda® should be used only under the direction of a physician. Since 2004, there have been close to 200 individual lawsuits filed against C.B. Fleet across the United States. The plaintiffs in these lawsuits allege that they have suffered kidney failure, chronic kidney disease, and end-stage renal disease as a direct result of using Fleet® Phospho-Soda® in a dose recommended by Fleet as "safe."

Medical research suggests that the incident rate of kidney failure associated with the use of oral sodium phosphates, such as Phospho-Soda® is 1 in 1,000. The kidney damage caused by Phospho-soda is often called Acute Phosphate Nephropathy, Acute Renal Failure, Chronic Renal Failure, or Acute Nephrocalcinosis.

If you or a loved one have suffered kidney disease or kidney damage that developed after taking Fleet® Phospho-soda® as a bowel cleanser in preparation for a colonoscopy or surgery, you may be entitled to compensation for your injury. Call one of our Fleet® Phospho-soda® lawyers today. We want to help.

Free Consultation

When you hire Richard Harris Law Firm, you get more than a Las Vegas injury lawyer—you get a partner who will work with you throughout your entire case. We have helped injured victims get the compensation they need for more than 30 years, and our Nevada injury lawyers are here for you, too. Don’t hesitate. Fill out an online consultation form or call (702) 444-4444 for a free and confidential case evaluation today.